Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triple-Negative Breast Cancer From the West African Source to the Caribbean Diaspora: A Phase II Randomized Clinical Trial With Correlative Molecular and Population-Stratified Analysis in Women of African Ancestry With Metastatic Triple-Negative Breast Cancer.

NCT07528768 is registered in ClinicalTrials.gov with The University of The West Indies as lead sponsor.

NCT NCT07528768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07528768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triple-Negative Breast Cancer From the West African Source to the Caribbean Diaspora: A Phase II Randomized Clinical Trial With Correlative Molecular and Population-Stratified Analysis in Women of African Ancestry With Metastatic Triple-Negative Breast Cancer.
Lead sponsor
The University of The West Indies
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 1, 2027
Completion date
June 1, 2034
Enrollment
750 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic triple-negative breast cancer, triple negative breast cancer